Premaitha Health PLC Company Profile (LON:NIPT)

About Premaitha Health PLC (LON:NIPT)

Premaitha Health PLC logoPremaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time. The Company operates in the United Kingdom and Rest of the World.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: Enterprise Software
  • Sub-Industry: N/A
  • Symbol: LON:NIPT
  • CUSIP: N/A
  • Web: www.premaitha.com/
Capitalization:
  • Market Cap: £18.54 million
  • Outstanding Shares: 228,163,000
Average Prices:
  • 50 Day Moving Avg: GBX 8.51
  • 200 Day Moving Avg: GBX 9.93
  • 52 Week Range: GBX 7 - GBX 14.40
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: £3.28 million
  • Price / Sales: 5.65
  • Book Value: GBX (0.01) per share
  • Price / Book: -13.54
Profitability:
  • EBIDTA: ($5,910,000.00)
  • Net Margins: -245.15%
  • Return on Equity: -9,579.58%
  • Return on Assets: -73.52%
Misc:
  • Average Volume: 524,441 shs.
 

Frequently Asked Questions for Premaitha Health PLC (LON:NIPT)

What is Premaitha Health PLC's stock symbol?

Premaitha Health PLC trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."

Where is Premaitha Health PLC's stock going? Where will Premaitha Health PLC's stock price be in 2017?

0 brokerages have issued 12-month price targets for Premaitha Health PLC's stock. Their forecasts range from GBX 18 to GBX 18. On average, they expect Premaitha Health PLC's stock price to reach GBX 18 in the next twelve months. View Analyst Ratings for Premaitha Health PLC.

Who are some of Premaitha Health PLC's key competitors?

Who are Premaitha Health PLC's key executives?

Premaitha Health PLC's management team includes the folowing people:

  • Barry Kenneth Hextall, Chief Financial Officer, Director
  • William Tzocor Denman IV, Executive Director
  • Adam Reynolds, Non-Executive Chairman of the Board
  • Alan Chang, Director
  • Bill Chang, Director
  • Nicholas Mustoe, Non-Executive Director

How do I buy Premaitha Health PLC stock?

Shares of Premaitha Health PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Premaitha Health PLC's stock price today?

One share of Premaitha Health PLC stock can currently be purchased for approximately GBX 8.13.


MarketBeat Community Rating for Premaitha Health PLC (LON NIPT)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about Premaitha Health PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Premaitha Health PLC (LON:NIPT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: GBX 18

Analysts' Ratings History for Premaitha Health PLC (LON:NIPT)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2017FinnCapReiterated RatingCorporateView Rating Details
7/4/2016Panmure GordonReiterated RatingBuyGBX 24View Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Premaitha Health PLC (LON:NIPT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Premaitha Health PLC (LON:NIPT)
Current Year EPS Consensus Estimate: $-2.340 EPS

Dividends

Dividend History for Premaitha Health PLC (LON:NIPT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Premaitha Health PLC (LON:NIPT)
Insider Trades by Quarter for Premaitha Health PLC (LON:NIPT)
Insider Trades by Quarter for Premaitha Health PLC (LON:NIPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/17/2015Hextall,Barry KennethInsiderBuy180,736GBX 18£32,532.48
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Premaitha Health PLC (LON:NIPT)
Latest Headlines for Premaitha Health PLC (LON:NIPT)
Source:
DateHeadline
lse.co.uk logoFurther Patent Infringement Claims - London South East (registration) (blog)
www.lse.co.uk - September 8 at 6:24 AM
finance.yahoo.com logoBefore You Buy Premaitha Health PLC’s (AIM:NIPT), You Should Consider This
finance.yahoo.com - September 8 at 6:24 AM
americanbankingnews.com logoPremaitha Health PLC (NIPT) Stock Rating Reaffirmed by FinnCap
www.americanbankingnews.com - August 28 at 5:36 PM
americanbankingnews.com logoPremaitha Health PLC's (NIPT) "Corporate" Rating Reaffirmed at FinnCap
www.americanbankingnews.com - June 17 at 1:38 PM
morningstar.co.uk logoPremaitha Launches Prenatal Testing Product Sage In Asia Pacific
www.morningstar.co.uk - June 16 at 8:11 AM
morningstar.co.uk logoPremaitha Health Highlights Progress By Yourgene Acquisition In India
www.morningstar.co.uk - June 5 at 8:55 AM
americanbankingnews.com logoPremaitha Health PLC (NIPT) Rating Reiterated by FinnCap
www.americanbankingnews.com - May 28 at 5:14 PM
lse.co.uk logoPremaitha establishes first service lab in Asia - London South East (registration) (blog)
www.lse.co.uk - November 22 at 10:41 AM
biz.yahoo.com logoFull Year 2016 Premaitha Health PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 30 at 11:39 AM
lse.co.uk logoInvestment agreement extension with Thermo Fisher - London South East (registration) (blog)
www.lse.co.uk - September 23 at 5:57 PM
uk.finance.yahoo.com logoPremaitha propels prenatal test into Indian market
uk.finance.yahoo.com - February 3 at 3:46 AM
uk.finance.yahoo.com logoPremaitha expands prenatal product into two new markets
uk.finance.yahoo.com - January 27 at 12:05 PM
lse.co.uk logoREPEAT: Premaitha Welcomes Recommendation On NHS Pre-Natal Screening - London South East (registration) (blog)
www.lse.co.uk - January 17 at 7:39 PM
uk.finance.yahoo.com logoPremaitha Health confident about full year after Thermo Fisher deal
uk.finance.yahoo.com - December 14 at 11:42 AM
biz.yahoo.com logoHalf Year 2016 Premaitha Health PLC Earnings Release - Time Not Supplied
biz.yahoo.com - December 14 at 7:07 AM
uk.finance.yahoo.com logoPremaitha Health PLC Premaitha Health signs Investment Agreement with Thermo Fisher Scientific
uk.finance.yahoo.com - December 14 at 2:17 AM

Social

Social activity is not available for this stock.

Chart

Premaitha Health PLC (NIPT) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff